🔴 Noveris Health Sciences is trading 6.67% down today with no direct company catalyst found

Noveris Health Sciences is trading at CA$0.14 (-6.67%) with broader market risk-off sentiment potentially contributing.

• No new company announcement was identified for August 31, 2026.
• The latest company-specific development remains the proposed CA$500,000 convertible-debenture financing, expected to close around August 28, 2026.
• Major U.S. indices are lower as geopolitical tensions, higher oil prices, and renewed rate concerns weigh on markets; no direct causal company catalyst was found.